PAREXEL Informatics Among Cloud Top 500

195 West Street

Waltham, MA, 2451, United States

1 781 487 9900


PAREXEL Informatics Strengths, Domain Expertise, and Key Differentiators

Perceptive Informatics has been leading the life sciences apps marketplace by completing more than 500 integration projects to connect disparate applications across clinical technology systems provided by multiple vendors. PAREXEL introduced the latest version of its Regulatory Information Management (RIM) platform: LIQUENT InSight 6.0. and IMPACT Express Clinical Trial Management System (CTMS), a cost-effective clinical trial management solution to simplify clinical trial management and monitoring for small to mid-sized biopharmaceutical companies.

PAREXEL and EMC Corporation have allied to offer an end-to-end Regulatory Information Management (RIM) and Regulatory Content Management solution. By combining the PAREXEL LIQUENT InSight Regulatory Information Management platform and EMC Documentum for Life Sciences software solution suite, PAREXEL will provide life sciences companies with a complete solution for a product's entire regulatory lifespan. The offering is available through PAREXEL's Regulatory Cloud.

PAREXEL Informatics Recent Developments

In October 2018 PAREXEL developed several new solutions that take a patient-centric approach to address drug development. Built on the Perceptive Cloud platform and leveraging PAREXEL's relationship with Microsoft, the solutions incorporate mobile and wearable technology to increase access to data and improve the patient experience in clinical research.

The first solution is designed to enable health care staff and first-line clinicians to communicate time-sensitive events to study staff. Leveraging Microsoft Azure App Services, the technology will generate health alerts through data transmission from mobile devices, gathered at the patient home or in the field and forwarded automatically whenever there is connectivity. Staff and investigators will then be automatically informed and could proactively address any threat to patient safety, potentially decreasing the risk of patient mortality and morbidity.

PAREXEL Informatics Mergers and Acquisitions (M&A) Activities

In 2017, Parexel Informatics was acquired by Pamplona Capital for $5 billion. PAREXEL leadership expects with the acquisition, PAREXEL company to be in a better position for growth and success.

PAREXEL Informatics Customers in ARTW Customer Database

Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying PAREXEL Informatics applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of PAREXEL Informatics and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified Parexel Biotech, IMPACT CTMS customers.

PAREXEL Informatics Overview

Ownership: - Pamplona Capital Management

Number of Employees: 18660

Functional Markets: ERP Services and Operations Management,

Key Verticals: Life Sciences,

PAREXEL Informatics Key Enterprise and Cloud Applications

Parexel Biotech, IMPACT CTMS

PAREXEL Informatics Revenues, $M:

Type/Year20182019YoY Growth, %
Total Revenues, $M Subscribe Subscribe Subscribe
Enterprise Applications Revenues, $M Subscribe Subscribe Subscribe
Cloud Applications Revenues, $M Subscribe Subscribe Subscribe

* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.

PAREXEL Informatics Revenue Breakdown By Type, $M:

TypeLicenseServicesHardwareSupport & MaintenanceSaaS
% of Total Revenues Subscribe Subscribe Subscribe Subscribe Subscribe
Revenues, $M Subscribe Subscribe Subscribe Subscribe Subscribe

PAREXEL Informatics Revenues By Region, $M

Region% of Total Revenues2019 Total Revenues, $M2019 Enterprise Applications Revenues, $M2019 Cloud Applications Revenues, $M
Americas Subscribe Subscribe Subscribe Subscribe
EMEA Subscribe Subscribe Subscribe Subscribe
APAC Subscribe Subscribe Subscribe Subscribe
Total Subscribe Subscribe Subscribe Subscribe

PAREXEL Informatics Direct vs Indirect sales

RegionDirect SalesIndirect SalesTotal
Type % Subscribe Subscribe Subscribe
Revenues, $M Subscribe Subscribe Subscribe

PAREXEL Informatics Customers - Breakdown by Geo, Size, Vertical and Product

List of Verified PAREXEL Informatics Customers

No. of PAREXEL Informatics Customers: x

No. of PAREXEL Informatics Enterprise Applications Customers: x

No. of PAREXEL Informatics Cloud Customers: x

No. of PAREXEL Informatics Cloud Subscribers: x

Pfizer, Merck, Almirall, Sanofi Pasteur, and Veeda Oncology are among Perceptive's key customers. In addition, Perceptive's DataLabs Electronic Data Capture (EDC) solution has been implemented by 15 of the top 35 global biopharmaceutical companies. Since the market introduction of LIQUENT InSight in 2004, more than 40 companies (including 14 of the top 20 pharmaceutical companies) have selected the LIQUENT InSight platform as their single source of regulatory information.

The IMPACT solution is the world's most utilized enterprise clinical trial management system (CTMS), with over 26,000 end users. PAREXEL was initially focused on supporting German and Japanese pharmaceutical firms, Parexel has expanded and now has clients in more than 100 countries worldwide.

PAREXEL Informatics Market Opportunities, M&A and Geo Expansions

With the help of its parent PAREXEL, Perceptive was able to market its software solutions to emerging and mid-size biopharmaceutical companies, advising them on best-practices strategies to maximize efficiencies and support more effective decision-making in clinical development and commercialization.

In September 2018, PAREXEL and Datavant partnered to enhance clinical study design and operations, as well as the generation of real-world evidence. As part of PAREXEL's focus on providing innovative scientific and clinical data strategies, the collaboration will enable the linking of healthcare data from a variety of real-world and clinical study data sources to improve drug development and commercialization processes. Datavant's technology enables the linking of traditional healthcare data sources including electronic medical records (EMRs), claims, and diagnostics with additional emerging sources, such as genomics, socioeconomic data, data from wearable devices, behavioral data and more.

The two companies also aim to advance hybrid study delivery to help life science companies more effectively generate evidence and demonstrate product value. A recent report released by the Economist Intelligence Unit and commissioned by PAREXEL found that drugs developed using real-world data had a 21 percent higher likelihood of launch, and real-world data studies resulted in reduced recruitment time. The report also identified advanced data analytics - including the sharing of data across established siloes as a key enabler to innovation in drug development and commercialization.

PAREXEL Informatics Risks and Challenges

Consolidation among the big pharmas could impact long-term growth for Parexel.

PAREXEL Informatics Ecosystem, Partners, Resellers and SI

Headquartered near Boston, Massachusetts, PAREXEL has offices in 82 locations in 51 countries around the world, and had approximately 18660 employees. Among its partners are, Clinical Ink, Cytel, ERT, Formedix, HighPoint Solutions, IBM, iCardiac Technologies, Metrics Champion Consortium, Microsoft, Tessella, TIBCO, pharmaSOL, Catalen. PAREXEL is on its way to strengthen its drug development and commercialization in Asia/Pacific through a new Hong Kong presence established by its strategic healthcare consulting Health Advances subsidiary.

PAREXEL Informatics Cloud Infrastructure Insights

Subscribe to read more about:

  • PAREXEL Informatics Public Cloud and Infrastructure (IaaS)
  • PAREXEL Informatics Platform (PaaS)
  • PAREXEL Informatics Application Delivery
  • PAREXEL Informatics Private Cloud and Data Centers

Research Methodology

Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.

Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).

For additional information on our methodologies, here's the link: Us

Copyright © 2021, APPS RUN THE WORLD